We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$7.65B
AUM Growth
+$112M
Cap. Flow
-$72.9M
Cap. Flow %
-0.95%
Top 10 Hldgs %
44.49%
Holding
170
New
4
Increased
63
Reduced
46
Closed
12

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$105M
2
KVUE icon
Kenvue
KVUE
+$6.36M
3
AVGO icon
Broadcom
AVGO
+$2.78M
4
MSFT icon
Microsoft
MSFT
+$1.16M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$671K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$80.4M
2
LLY icon
Eli Lilly
LLY
+$30.1M
3
CSCO icon
Cisco
CSCO
+$22.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$12.1M
5
AAPL icon
Apple
AAPL
+$10M

Sector Composition

Rank Sector Weight
1 Technology 46.65%
2 Healthcare 23.02%
3 Industrials 12.1%
4 Consumer Staples 6.52%
5 Consumer Discretionary 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
26
Stryker
SYK
$129B
$113M 1.48%
313,270
+50
+0% +$17.3K
CSCO icon
27
Cisco
CSCO
$452B
$110M 1.44%
2,063,021
-465,840
-18% -$22.7M
ELV icon
28
Elevance Health
ELV
$82.1B
$109M 1.43%
209,939
+60
+0% +$32.1K
MRK icon
29
Merck
MRK
$323B
$108M 1.41%
952,200
+1,168
+0.1% +$139K
TRMB icon
30
Trimble
TRMB
$13B
$105M 1.37%
1,690,910
+477
+0% +$26.6K
IT icon
31
Gartner
IT
$9.87B
$91.5M 1.2%
180,641
GWW icon
32
W.W. Grainger
GWW
$66B
$85.2M 1.11%
81,980
+250
+0.3% +$242K
ROK icon
33
Rockwell Automation
ROK
$51.9B
$80.9M 1.06%
301,300
+1,000
+0.3% +$265K
ITW icon
34
Illinois Tool Works
ITW
$81.9B
$80.8M 1.06%
308,174
-7,165
-2% -$1.76M
UNP icon
35
Union Pacific
UNP
$178B
$78.6M 1.03%
318,853
-26,743
-8% -$6.48M
LIN icon
36
Linde
LIN
$234B
$64.9M 0.85%
136,060
TXN icon
37
Texas Instruments
TXN
$255B
$54.9M 0.72%
266,007
+409
+0.2% +$82.2K
LECO icon
38
Lincoln Electric
LECO
$14.1B
$53.8M 0.7%
280,279
-1,991
-0.7% -$382K
GPC icon
39
Genuine Parts
GPC
$17.6B
$53.6M 0.7%
383,800
+1,800
+0.5% +$250K
CL icon
40
Colgate-Palmolive
CL
$73.6B
$50.8M 0.66%
489,200
+200
+0% +$20.4K
PPG icon
41
PPG Industries
PPG
$26.4B
$50.3M 0.66%
379,580
MKC icon
42
McCormick & Company Non-Voting
MKC
$13.6B
$46.1M 0.6%
560,016
CNI icon
43
Canadian National Railway
CNI
$78B
$45M 0.59%
384,000
-24,000
-6% -$2.8M
ABT icon
44
Abbott
ABT
$182B
$44.9M 0.59%
394,071
-13,033
-3% -$1.43M
AMGN icon
45
Amgen
AMGN
$203B
$44.8M 0.59%
139,097
-2,165
-2% -$708K
ETN icon
46
Eaton
ETN
$155B
$44.3M 0.58%
133,526
-551
-0.4% -$168K
KMB icon
47
Kimberly-Clark
KMB
$37B
$42.8M 0.56%
301,090
-10
-0% -$1.42K
FERG icon
48
Ferguson
FERG
$45.4B
$42.1M 0.55%
211,892
+1,336
+0.6% +$271K
UL icon
49
Unilever
UL
$132B
$37.3M 0.49%
510,511
+2,743
+0.5% +$190K
UPS icon
50
United Parcel Service
UPS
$96B
$37M 0.48%
271,495
-3,302
-1% -$434K

Similar funds

Saturna Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Saturna Capital held 170 positions worth $7.65B, up 1.5% from $7.53B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Saturna Capital's Q3 2024 filing shows 4 new, 63 increased, 46 reduced and 12 closed positions. Its largest new stake was Argan: 3,894 shares worth $395K. The largest sale was Idexx Laboratories, an estimated $80.4M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.

  • Saturna Capital's largest Q3 2024 buy was Argan: 3,894 shares worth $395K.
  • Saturna Capital added most to AbbVie in Q3 2024, an estimated $105M increase.
  • Saturna Capital's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $30.1M.
  • Saturna Capital fully exited Idexx Laboratories in Q3 2024, selling an estimated $80.4M.
  • Saturna Capital's ten largest holdings make up 44% of its $7.65B portfolio in Q3 2024.
  • Saturna Capital opened 4 new positions and closed 12 in Q3 2024.
  • Saturna Capital's portfolio value rose 1.5% quarter-over-quarter to $7.65B.

Based on Saturna Capital's 13F filing for Q3 2024, filed 5 Nov 2024.